There is absolutely no question that incretin-based glucose-lowering medications are actually effective glucose-lowering agents. lesions, and possibly, over time, pancreatic cancers. Other issues relate with a potential risk for the upsurge in thyroid cancers. A couple of obviously conflicting data which have been provided in preclinical research and in epidemiologic research. To provide a knowledge… Continue reading There is absolutely no question that incretin-based glucose-lowering medications are actually